Loading...
Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
BACKGROUND: Current standard therapy commonly followed for chronic Hepatitis C Virus (HCV) in Pakistan is interferon alpha plus ribavirin combination therapy (IFN α/ribavirin) and pegylated interferon plus ribavirin (PegIFN/ribavirin). PegIFN/ribavirin has increased rate of sustained virological res...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3113307/ https://ncbi.nlm.nih.gov/pubmed/21575275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|